This PDF is the current document as it appeared on Public Inspection on 08/09/2016 at 08:45 am.
Notice of registration.
Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.End Preamble Start Supplemental Information
The companies listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.
|Mylan Pharmaceuticals, Inc.||80 FR 75691||December 3, 2015.|
|Hospira||81 FR 1208||January 11, 2016.|
|Cambrex Charles City||81 FR 14892||March 18, 2016.|
|Pharmacore||81 FR 15565||March 23, 2016.|
|Mallinckrodt LLC||81 FR 15566||March 23, 2016.|
|Meda Pharmaceuticals, Inc.||81 FR 15560||March 23, 2016.|
|Stepan Company||81 FR 20417||April 7, 2016|
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.Start Signature
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18922 Filed 8-9-16; 8:45 am]
BILLING CODE 4410-09-P